Pradaxa Adverse Events Extremely High According to Reporting System

According to the Institute for Safe Medication Practices (ISMP), in 2012 the US Food and Drug Administration (FDA) Adverse Event Reporting System received more than 3,200 reports of problems associated with the drug Pradaxa.

Pradaxa is an anticoagulant blood thinning medication that is used to reduce the risk of stroke in patients with non-valvular atrial fibrillation (AF). However, Pradaxa has been linked to bleeding problems like hemorrhaging, acute renal failure, stroke and death. Some media outlets have linked the drug to more than 500 deaths.

Manufacturer Boehringer Ingelheim introduced the drug in October 2010 as an alternative to warfarin for stroke prevention. In addition to issues with bleeding, the drug has been linked to the increased potential for viral infections. A report by the ISMP that was delivered to the FDA this spring suggests that Pradaxa is five times riskier than warafin when it comes to adverse health events.

Currently, there are more than 200 lawsuits pending against Boehringer Ingelheim throughout the country, and a multidistrict litigation (MDL) is expected to go before a judge over the next year.

If you have been injured or have had a loved one killed by taking Pradaxa, contact our drug injury lawyers. We offer no obligation consultations, and have the knowledge to hold a pharmaceutical company accountable for its actions. Call us toll-free today at (888)841-9623.

Zoll & Kranz, LLC – Dangerous Medical Drug & Device Attorneys